MetaADEDB 2.0: a comprehensive database on adverse drug events

Area of Science:

• Pharmacovigilance
• Biomedical Informatics
• Drug Safety

Background:

• The initial MetaADEDB database, released in 2013, served as a valuable resource for adverse drug event (ADE) information.
• The previous version had not been updated for over seven years, limiting its current utility.
• There is a continuous need for up-to-date, integrated data on drug-ADE associations for effective safety monitoring.

Purpose of the Study:

• To report the second version of MetaADEDB (MetaADEDB 2.0), an integrated online database for adverse drug events.
• To enhance the comprehensiveness and recency of drug-ADE association data.
• To provide an improved, user-friendly platform for drug safety research.

Main Methods:

• Integrated new data from the U.S. FDA Adverse Event Reporting System (FAERS) and Canada Vigilance Adverse Reaction Online Database.
• Expanded the database by incorporating data from the original three sources.
• Developed a new, user-friendly web interface for data access, search, and analysis.

Main Results:

• The new version contains 744,709 drug-ADE associations, linking 8,498 drugs with 13,193 ADEs.
• This represents a significant increase of over 40% in drug-ADE associations compared to the previous version.
• A new web interface facilitates easier data exploration and analysis.

Conclusions:

• MetaADEDB 2.0 offers a substantially expanded and updated collection of drug-ADE information.
• The enhanced database serves as a critical tool for drug safety assessment.
• This resource supports ongoing research in drug discovery and development by providing comprehensive pharmacovigilance data.